IL1B and cancer: By conducting these experiments in non-tumor-bearing mice, we specifically isolated immunological changes attributable to HDM and IL-1β, avoiding confounding effects from carcinogen-induced or oncogene-driven inflammation seen in cancer models (68, 69).